Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications

Area of Science:

• Microbiology
• Oncology
• Metabolomics

Background:

• Colorectal cancer (CRC) is a major global health concern.
• The gut microbiota and its metabolites play a role in CRC development.
• Microbial metabolites can act as oncogenic factors in CRC.

Purpose of the Study:

• To review metabolomics techniques for studying microbial metabolites.
• To summarize the mechanisms of microbial metabolites in CRC pathogenesis.
• To discuss clinical applications of microbial metabolites in CRC diagnosis and treatment.

Main Methods:

• Review of current metabolomics technologies.
• Analysis of scientific literature on microbial metabolites and CRC.
• Synthesis of data on host-microbiota metabolism interactions.

Main Results:

• Metabolomics enables comprehensive profiling of microbiota-derived metabolites.
• Specific microbial metabolites are implicated in CRC initiation and progression.
• Understanding these interactions is crucial for CRC research.

Conclusions:

• Metabolomics is a powerful tool for investigating gut microbiota and CRC.
• Microbial metabolites represent potential biomarkers for CRC diagnosis.
• Targeting microbial metabolites offers therapeutic strategies for CRC.